HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daiki Omata Selected Research

Daiki Omata Research Topics

Disease

20Neoplasms (Cancer)
12/2022 - 01/2010
2Human Influenza (Influenza)
08/2020 - 01/2019
1Glioblastoma (Glioblastoma Multiforme)
11/2023
1Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2021
1Shock
03/2016
1Hyperthermia
01/2013
1Mucositis
05/2011
1Kaposi Sarcoma (Kaposi's Sarcoma)
05/2011
1Ovarian Neoplasms (Ovarian Cancer)
05/2011

Drug/Important Bio-Agent (IBA)

9Liposomes (Liposome)IBA
03/2016 - 01/2010
5Peptides (Polypeptides)IBA
07/2013 - 02/2010
4liposomal doxorubicin (Doxil)FDA Link
12/2021 - 05/2011
4LipidsIBA
06/2021 - 01/2020
4Syndecan-2IBA
05/2011 - 01/2010
3Lipid NanoparticlesIBA
08/2020 - 01/2019
3LigandsIBA
05/2011 - 02/2010
2Cisplatin (Platino)FDA LinkGeneric
11/2023 - 06/2021
2Vaccine AdjuvantsIBA
12/2022 - 01/2019
21-dodecylpyridoxal (PLD)IBA
12/2021 - 06/2021
2Contrast MediaIBA
11/2020 - 07/2013
2VaccinesIBA
08/2020 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2013 - 05/2011
2SyndecansIBA
05/2011 - 02/2010
2Laminin (Merosin)IBA
05/2011 - 08/2010
1Therapeutic UsesIBA
11/2023
1Temozolomide (Temodar)FDA LinkGeneric
11/2023
1Antineoplastic Agents (Antineoplastics)IBA
11/2023
1LuciferasesIBA
11/2023
1ProdrugsIBA
01/2022
1GlucuronidaseIBA
01/2022
1EnzymesIBA
01/2022
1Bevacizumab (Avastin)FDA Link
06/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021
1AntigensIBA
08/2020
1CPG-oligonucleotideIBA
01/2019
1Biocompatible Materials (Biomaterials)IBA
07/2013
1laminin AIBA
02/2010

Therapy/Procedure

10Therapeutics
11/2023 - 01/2010
5Microbubbles
11/2023 - 01/2020
5Immunotherapy
12/2022 - 01/2013
2Precision Medicine
08/2020 - 06/2015
1Immunomodulation
04/2022
1Drug Therapy (Chemotherapy)
06/2021